NCT05268588 mHealth India Postnatal Health Intervention Effectiveness
| NCT ID | NCT05268588 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Health Knowledge, Attitudes, Practice |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,100 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,100 participants in total. It began in 2025-01-20 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to assess the effectiveness of a culturally-tailored mobile interactive education and support group intervention to supplement standard postpartum care activities in comparison to standard care alone on health-related behaviors and health outcomes in a randomized controlled trial among 2100 postpartum Indian women living in 3 geographically diverse Indian states to estimate the impact on maternal and neonatal health-related knowledge, health-related behaviors, and health outcomes. The investigators also seek to characterize mechanisms of impact including knowledge, social support, self-efficacy, and behavior change, and determine the cost-effectiveness.
Eligibility Criteria
Inclusion Criteria: * Pregnant (28-32 weeks gestational age) * Speak local language * Personal mobile phone or willing to accept study phone * Able to provide informed consent Exclusion Criteria: * Do not speak local language * No personal phone or unwilling to accept study phone * Unable to provide informed consent
Contact & Investigator
Alison M El Ayadi, ScD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05268588 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Health Knowledge, Attitudes, Practice. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05268588 currently recruiting?
Yes, NCT05268588 is actively recruiting participants. Contact the research team at alison.elayadi@ucsf.edu for enrollment information.
Where is the NCT05268588 trial being conducted?
This trial is being conducted at Chandīgarh, India, Bhopal, India, New Delhi, India.
Who is sponsoring the NCT05268588 clinical trial?
NCT05268588 is sponsored by University of California, San Francisco. The principal investigator is Alison M El Ayadi, ScD at University of California, San Francisco. The trial plans to enroll 2,100 participants.